US Equity
PRQR
— ProQR Therapeutics NVProQR Therapeutics NV is a genetic medicine company developing RNA therapies for the treatment of inherited retinal diseases.
💰 Market cap: $230.07M📍 Zernikedreef 9, LEIDEN, ZUID-HOLLAND, 2333 CK NL🏷️ Biotechnology & Medical Research💵 Previous close: $1.72🔢 6,776 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $1.72 |
| 2026-07-23 | $1.79 |
| 2026-07-22 | $1.81 |
| 2026-07-21 | $1.88 |
| 2026-07-20 | $1.76 |
| 2026-07-17 | $1.70 |
| 2026-07-16 | $1.67 |
| 2026-07-15 | $1.77 |
| 2026-07-14 | $1.70 |
| 2026-07-13 | $1.70 |
| 2026-07-10 | $1.73 |
| 2026-07-09 | $1.76 |
| 2026-07-08 | $1.68 |
| 2026-07-07 | $1.66 |
| 2026-07-06 | $1.72 |
| 2026-07-02 | $1.81 |
| 2026-07-01 | $1.75 |
| 2026-06-30 | $1.86 |
| 2026-06-29 | $1.83 |
| 2026-06-26 | $1.53 |
| 2026-06-25 | $1.56 |
| 2026-06-24 | $1.81 |
| 2026-06-23 | $1.89 |
| 2026-06-22 | $1.88 |
| 2026-06-18 | $1.89 |
| 2026-06-17 | $1.67 |
| 2026-06-16 | $1.52 |
| 2026-06-15 | $1.56 |
| 2026-06-12 | $1.44 |
| 2026-06-11 | $1.44 |
| 2026-06-10 | $1.41 |
| 2026-06-09 | $1.47 |
| 2026-06-08 | $1.53 |
| 2026-06-05 | $1.50 |
| 2026-06-04 | $1.53 |
| 2026-06-03 | $1.47 |
| 2026-06-02 | $1.47 |
| 2026-06-01 | $1.42 |
| 2026-05-29 | $1.58 |
| 2026-05-28 | $1.57 |
| 2026-05-27 | $1.56 |
| 2026-05-26 | $1.57 |
| 2026-05-22 | $1.56 |
| 2026-05-21 | $1.44 |
| 2026-05-20 | $1.43 |
| 2026-05-19 | $1.43 |
| 2026-05-18 | $1.51 |
| 2026-05-15 | $1.59 |
| 2026-05-14 | $1.65 |
| 2026-05-13 | $1.70 |
| 2026-05-12 | $1.60 |
| 2026-05-11 | $1.61 |
| 2026-05-08 | $1.58 |
| 2026-05-07 | $1.58 |
| 2026-05-06 | $1.72 |
| 2026-05-05 | $1.63 |
| 2026-05-04 | $1.64 |
| 2026-05-01 | $1.55 |
| 2026-04-30 | $1.57 |
| 2026-04-29 | $1.54 |
| 2026-04-28 | $1.48 |